MSC - Targets for Atherosclerosis Therapy

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2018 Dec 29

PMID 30591619

Citations 7

Authors

Ines Colmegna

Ursula Stochaj

Affiliations

Soon will be listed here.

Citing Articles

Integrin beta 3-overexpressing mesenchymal stromal cells display enhanced homing and can reduce atherosclerotic plaque.

Hu H, Xiao X, Li T, Liu D, Geng X, Han M World J Stem Cells. 2023; 15(9):931-946.

PMID: 37900938 PMC: 10600744. DOI: 10.4252/wjsc.v15.i9.931.

Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment specific factors involved in the regulation of MSC plasticity.

Tan L, Liu X, Dou H, Hou Y Genes Dis. 2022; 9(2):296-309.

PMID: 35224147 PMC: 8843883. DOI: 10.1016/j.gendis.2020.10.006.

Vascular Stem/Progenitor Cells in Vessel Injury and Repair.

Tao J, Cao X, Yu B, Qu A Front Cardiovasc Med. 2022; 9:845070.

PMID: 35224067 PMC: 8866648. DOI: 10.3389/fcvm.2022.845070.

The involving progress of MSCs based therapy in atherosclerosis.

Lin Y, Zhu W, Chen X Stem Cell Res Ther. 2020; 11(1):216.

PMID: 32503682 PMC: 7275513. DOI: 10.1186/s13287-020-01728-1.

The therapeutic potential of mesenchymal stem cells for cardiovascular diseases.

Guo Y, Yu Y, Hu S, Chen Y, Shen Z Cell Death Dis. 2020; 11(5):349.

PMID: 32393744 PMC: 7214402. DOI: 10.1038/s41419-020-2542-9.

References

Wang S, Hu S, Zhang Q, Xia A, Jiang Z, Chen X . Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties. PLoS One. 2015; 10(8):e0136026. PMC: 4546153. DOI: 10.1371/journal.pone.0136026. View

Madamanchi N, Runge M . Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007; 100(4):460-73. DOI: 10.1161/01.RES.0000258450.44413.96. View

Galkina E, Ley K . Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol. 2009; 27:165-97. PMC: 2734407. DOI: 10.1146/annurev.immunol.021908.132620. View

Kizilay Mancini O, Shum-Tim D, Stochaj U, Correa J, Colmegna I . Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression. Stem Cell Res Ther. 2015; 6:140. PMC: 4529693. DOI: 10.1186/s13287-015-0127-9. View

Kizilay Mancini O, Lora M, Shum-Tim D, Nadeau S, Rodier F, Colmegna I . A Proinflammatory Secretome Mediates the Impaired Immunopotency of Human Mesenchymal Stromal Cells in Elderly Patients with Atherosclerosis. Stem Cells Transl Med. 2017; 6(4):1132-1140. PMC: 5442842. DOI: 10.1002/sctm.16-0221. View